Vidyya Medical News Service
*
Volume 6 Issue 330 Published - 14:00 UTC 08:00 EST 25-Nov-2004 Next Update - 14:00 UTC 08:00 EST 26-Nov-2004
little clear gif used for spacer
.
*

FDA approves Vesicare(r) for treatment of overactive bladder
Vesicare® (solifenacin succinate) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of overactive bladder (OAB) with symptoms of urgency, frequency, and urge incontinence.  more

*
Prescribing information: Vesicare (solifenacin succinate) (PDF)
VESIcare is indicated for the treatment of overactive bladder with symptoms of urgency, frequency, and urge incontinence. The most common side effects are dry mouth, constipation, and blurred vision. The recommended dose of VESIcare is 5 mg once daily. Get the full prescribing information, complete with a patient information sheet immediately following in today's issue of Vidyya.  more

*
FDA announces enhancement to Accutane (isotretinoin) risk management program
The Food and Drug Administration (FDA) announced the strengthening of the risk minimization action plan (RiskMAP) for Accutane (isotretinoin) and its generic equivalents. Isotretinoin is a drug indicated for the treatment of a specific type of severe acne (severe recalcitrant nodular acne) that is not responsive to other therapies. more

 


*
BMJ Editor: FDA tried to discredit whistleblower over drug safety claims
The Food and Drug Administration (FDA) tried to discredit one of its own experts after he told a US Senate hearing that the FDA had failed to protect the public over rofecoxib (Vioxx), according to two articles published online by the BMJ today.  more

*
Information for patients: Dysphagia
People with dysphagia have difficulty swallowing and may also experience pain while swallowing. Some people may be completely unable to swallow or may have trouble swallowing liquids, foods, or saliva. Eating then becomes a challenge. Often, dysphagia makes it difficult to take in enough calories and fluids to nourish the body. more

*
Stress quadruples risk of asthma attack in children
Stress quadruples the risk of an asthma attack in children, and gives them a double bout of acute symptoms within 48 hours and around six weeks later, finds a small study in Thorax.  more

*
Leukemia patients survive with stem cell transplant
A new study published in the New England Journal of Medicine confirms that stem cells derived from the umbilical cords of newborn babies are a viable and effective transplant source for thousands of leukemia patients who have no other treatment option. more

 
little clear gif used for a space